BVI completed the acquisition of Arcadophtha.

BVI, a provider of ophthalmic equipments and services, completed the acquisition of Arcadophtha, an ophthalmic company specializing in silicon oils, gases and perfluorocarbons used in vitreoretinal surgery. Financial terms were not disclosed. "We are thrilled to partner with BVI and firmly believe that our combined offering of physician-preferred products will continue to contribute to outstanding patient outcomes," Gerard Reboul, Arcadophtha Co-Founder.